Congresses
Analytical Performance of a cfDNA-based Targeted Methylation Multi-cancer Early Detection Test for Population-scale Screening
April 14, 2021
Performance of a Cell-Free DNA-Based Multi-Cancer Detection Test as a Tool for Diagnostic Resolution of Symptomatic Cancers
Clinical Validation of a Targeted Methylation-Based Multi-Cancer Early Detection Test
Simultaneous Multi-Cancer Detection and Tissue of Origin Prediction Via Targeted Bisulfite Sequencing of Plasma Cell-Free DNA
October 16, 2020
Analytical Validation of a Multi-Cancer Early Detection Test With Tissue Localization Using a Cell-Free DNA-Based Targeted Methylation Assay
June 24, 2020
Classifier Performance of a cfDNA-Based Multi-Cancer Detection Test on Uncommon Cancer Types
HPV-Driven Cancers Show Distinct Methylation Signatures in Cell-Free DNA (cfDNA)
cfDNA Methylation Profiling Distinguishes Lineage-Specific Hematologic Malignancies
Tumor Methylation Patterns Accurately Measure Tumor Fraction in Cell-free DNA
May 29, 2020
Tumor Area and Microscopic Extent of Invasion to Estimate Circulating Tumor DNA Fraction in Plasma and Detectability of Colorectal Cancer
May 5, 2020
Simultaneous Multi-cancer Detection and Tissue of Origin (TOO) Localization Using Targeted Bisulfite Sequencing of Plasma Cell-free DNA (cfDNA)
May 3, 2020
AACR Virtual Annual Meeting I
April 28, 2020
Prediction of Cancer and Tissue of Origin in Individuals with Suspicion of Cancer Using a Cell-Free DNA Multi-Cancer Early Detection Test
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice
Tumor Area and Microscopic Extent of Invasion to Estimate Circulating Tumor DNA Fraction in Plasma and Detectability of Colorectal Cancer
January 24, 2020
Performance of a Blood-based Test for the Detection of Multiple Cancer Types
January 23, 2020
Oral Presentation: Performance of A Blood-based Test for the Detection of Multiple Cancer Types
Blood-based cancer detection in plasma cell-free DNA (cfDNA): evaluating clinical and pathologic tumor characteristics in participants with breast cancer
December 13, 2019
Oral Presentation: Novel non-invasive cell-free nucleic acid-based diagnostic test for liver fibrosis in patients with type II diabetes
November 10, 2019
Optimized Early Cancer Detection from Whole-Genome Sequencing of Cell-Free DNA
October 16, 2019
Oral Presentation: Simultaneous multi-cancer detection and tissue of origin (TOO) localization using targeted bisulfite sequencing of plasma cellfree DNA (cfDNA)
October 11, 2019
Simultaneous Multi-cancer Detection and Tissue of Origin (TOO) Localization Using Targeted Bisulfite Sequencing of Plasma Cell-free DNA (cfDNA)
Oral Presentation: Multi-cancer detection of early-stage cancers with simultaneous tissue localization using a plasma cfDNA-based targeted methylation assay
September 27, 2019
Trial in Progress: Cancer Screening Study With or Without Low Dose Lung CT to Validate a Multi-cancer Early Detection Blood Test: SUMMIT
September 8, 2019
Prognostic Significance of Blood-based Cancer Detection in Plasma Cell-free DNA (cfDNA): Evaluating Risk of Overdiagnosis
June 3, 2019
The Circulating Cell-free Genome Atlas (CCGA) Study: Follow-up (F/U) on Non-cancer Participants with Cancer-like Cell-free DNA Signals
June 1, 2019
The Circulating Cell-free Genome Atlas (CCGA) Study: Size Selection of Cell-free DNA (cfDNA) Fragments
Genome-wide Cell-free DNA (cfDNA) Methylation Signatures and Effect on Tissue of Origin (TOO) Performance
MODELING REDUCTIONS IN ABSOLUTE CANCER MORTALITY FROM DIAGNOSING CANCERS BEFORE METASTASIS, 2006-2015
May 22, 2019
Tumor Shedding into Cell-free DNA (cfDNA) is Associated with High-mortality Cancers
May 10, 2019
Detection of Tissue-specific RNA in the Plasma of Cancer Patients: A Circulating Cell-free Genome Atlas (CCGA) Substudy
May 9, 2019
Cell-free DNA (cfDNA) Fragment Length Patterns of Tumor- and Blood-derived Variants in Participants With and Without Cancer
April 2, 2019
Plasma-Based Molecular Testing for Early Detection of Lung Cancer
November 8, 2018
Plasma Cell-free DNA (cfDNA) Assays for Early Multi-cancer Detection: the Circulating Cell-free Genome Atlas (CCGA) Study
October 19, 2018
Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: exploratory analysis of the Circulating Cell-free Genome Atlas (CCGA) study
June 5, 2018
Genome-Wide Sequencing for Early Stage Lung Cancer Detection from Plasma Cell-Free DNA (cfDNA): The Circulating Cell-free Genome Atlas (CCGA) Study
June 4, 2018
Development of a comprehensive cell-free DNA (cfDNA) assay for early detection of multiple tumor types: The Circulating Cell-free Genome Atlas (CCGA) study
Breast Cancer Cell- free DNA (cfDNA) Profiles Reflect Underlying Tumor Biology: The Circulating Cell-free Genome Atlas (CCGA) Study
June 2, 2018
Development of Plasma Cell-Free DNA Assays for Early Cancer Detection: First Insights from the Circulating Cell- Free Genome Atlas (CCGA) Study
April 17, 2018
Development of Cell-Free Nucleic Acid-Based Tests for Detection of invasive breast cancer: The STRIVE Study
December 8, 2017
Conta: Methods for detecting trace amounts of contamination
July 24, 2017
Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer
June 3, 2017